By 2027, the Antiemetics Market is expected to reach US $ 20.40 billion, thanks to growth in the Chemotherapy segment. The report analyzes Antiemetics Market dynamics by region and Application industries.
Antiemetics Market Overview:Antiemetics are antiemetic medications that help with nausea and vomiting. Motion sickness, dizziness, pregnancy, mental stress, and food poisoning are just a few of the medical problems that cause nausea and vomiting. These treatments are frequently used to address the side effects of other medications such as opioid analgesics, chemotherapy, and general anesthesia. Moreover, antiemetics are also used to revert the venom effect, or sneak bites. To know about the Research Methodology :- Request Free Sample Report The report has covered the market trends from 2015 to forecast the market through 2027. 2020 is considered a base year however 2020's numbers are on the real output of the companies in the market. Special attention is given to 2020 and the effect of lockdown on the demand and supply, and also the impact of lockdown for the next two years on the market. Some companies have done good in lockdown also and specific strategic analysis of those companies is done in the report
Antiemetics Market Dynamics:Antiemetics Market size was valued at US$ 12.79 Bn. in 2020 and the total revenue is expected to grow at 2.5% through 2021 to 2027, reaching nearly US$ 3.70 Bn. When a patient is prescribed opioid analgesics, antiemetic medications are used to control nausea and vomiting; this is likely to drive the Antiemetics Market. Antiemetic medications are routinely provided to sedated patients for surgery to combat side effects, which is expected to be another important contributor to the consistent development of revenue. Furthermore, antiemetic medications are used in innovative drugs in clinical trials and new therapies, which might be another driver of market expansion. Detoxification, individuals undergoing alcohol addiction treatment, and food poisoning adverse effects are some of the main market drivers. Several limits and hurdles will stifle market expansion. During the projected period, challenges such as the lack of a suitable animal model that would match human reactions to antiemetic medication are expected to stifle growth. Furthermore, rising R&D costs, a piece of inadequate knowledge about the wide assortment of antiemetic and antinauseant drugs, and antiemetic drugs in the diagnosis stage that require improvements in clinical trial design for commercial exploitation are all possible future restraints to the global antiemetics market's overall growth. Nevertheless, technological advancements and untapped potential in developing countries present attractive opportunities in the global antiemetics market.
Partnerships, Collaborations, and Acquisitions:• Pfizer and BioNTech SE today signed an exclusive partnership agreement with COVAX for up to 40 million doses of the Pfizer-Biotech COVID-19 Vaccine, which is already in effect on January 22, 2021. • Pfizer Inc. agreed to acquire Amplyx Pharmaceuticals, Inc., on April 28, 2021, a private equity firm business focused on the discovery of medicines for devastating and chronic diseases that affect people with weakened immune systems. Fosmanogepix (APX001), Amplyx's main drug, is a unique experimental asset in development for the treatment of invasive fungal infections. • Pfizer Group announced a mega-contract with Gilead Sciences, Inc. to manufacture and supply Gilead's investigational antiviral redeliver, as one of several peripheral manufacturing organizations promoting initiatives to significantly increase the supply of the experimental treatment for COVID-19, on August 07, 2020. Pfizer will manufacture and supply redeliver for Gilead under the terms of the arrangement, which will be performed at Pfizer's McPherson, Kansas facility.
Antiemetics Market Segment Analysis:
The 5-HT3 receptor antagonists’ segment is leading the Application segment of the Antiemetics Market:During the projected period, the 5-HT3 receptor antagonists category will have the biggest market share. The 5-HT3 receptor's most well-known physiological functions are to coordinate emesis and regulate gastrointestinal motility. Currently available 5-HT3 receptor antagonists are used to treat nausea and vomiting caused by chemotherapy, radiotherapy, and anesthesia, as well as irritable bowel syndrome. Pain and drug addiction are two more therapeutic uses that have been investigated. The 5-HT3 receptor is one of several receptors that have a role in mediating nausea and vomiting, and as such, 5-HT3 receptor antagonists demonstrate optimal anti-emetic efficacy when used in combination with other medication types.
The Chemotherapy segment is dominating the Type segment of the Antiemetics Market:During the projection period, the Chemotherapy category will have the biggest market share. The reasons that might be ascribed to the daily increase in the number of cancer patients are boosting demand for this category. With the discovery of new, high-efficacy anticancer treatment drugs, the use of chemotherapy in advanced cancer patients has expanded. The global market is bolstered by increased expenditure in anti-cancer drug research and development, as well as increased demand for advanced cancer treatments. The worldwide chemotherapy medications market is also expected to benefit from increased awareness about cancer and its treatment, as well as early detection. The high cost of cancer therapy, on the other hand, acts as a barrier for patients, particularly in developing nations. Unfavorable reimbursement policies for chemotherapy medications are projected to stifle market expansion throughout the projection period in some countries.
Antiemetics Market Regional Insights:North America is estimated to dominate the growth of the Antiemetics Market. Due to the inevitable increased prevalence of patients undergoing chemotherapy and the availability of basic hospital infrastructure, North America is likely to dominate the worldwide antiemetic medicines market. In the projected period, the market is expected to expand due to rising acceptance of existing treatments, increased R&D expenditure in the pharmaceutical industry, and government efforts. Moreover, there is a higher prevalence of chemotherapy patients in the patient pool, as well as the availability of basic hospital facilities. Moreover, the high income and purchasing power of the individual, matured consumer base, high-end healthcare infrastructure, advanced technology are likely to boost the growth of the market in the coming future. The objective of the report is to present a comprehensive analysis of the Antiemetics Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Antiemetics Market dynamics, structure by analyzing the market segments and projecting the Antiemetics Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Antiemetics Market make the report investor’s guide.
Antiemetics Market Scope: Inquire before buying
Antiemetics Market, by Region• North America o US o Canada o Mexico • Europe o U.K o France o Germany o Italy o Spain o Sweden o CIS Countries o Rest of Europe • Asia Pacific o China o India o Japan o South Korea o Australia o ASEAN o Rest of Asia Pacific • The Middle East and Africa o South Africa o GCC Countries o Egypt o Nigeria o Rest of ME&A • South America o Brazil o Argentina o Rest of South America
Antiemetics Market Key Player• Teva Pharmaceutical • GlaxoSmithKline • Merck • Sanofi-Aventis • Bristol-Myers Squibb • Eli Lilly and Company • Pfizer • Astellas Pharma • Johnson & Johnson • Baxter International • Novartis AG • Abott laboratories • Daiichi Sankyo • Eisai Co., Ltd. • Tesaro • Roche
FAQs:1. What is the Antiemetics Market value in 2020? Ans: Antiemetics Market value in 2020 was estimated as 12.79 Billion USD. 2. What is the Antiemetics Market growth? Ans: The Antiemetics Market is anticipated to grow with a CAGR of 6.9% in the forecast period and is likely to reach USD 20.4 Billion by the end of 2027. 3. Which segment is expected to dominate the Antiemetics Market during the forecast period? Ans: North America is expected to dominate the global Antiemetics treatment market. Factors such as the existence of important companies, the high prevalence of Antiemetics patients in the region, and established healthcare infrastructure are some of the key factors responsible for the market's huge share. 4. Who are the key players in the Antiemetics Market? Ans: WATSON Pharmaceuticals (Changzhou), Hanson Pharmaceutical, Sandoz, Zhejiang Langhua Pharmaceuticals, Hansoh Pharmaceutical, Aurobindo Pharma, Jubilant Lifesciences, Torrent Pharmaceuticals, Sun Pharmaceutical, Lilly, Dr. Reddy’s Laboratories, Mylan Pharmaceuticals, Apotex Inc., Teva Pharmaceutical are key players of the global antiemetics market. 5. What is the key driving factor for the growth of the Antiemetics Market? Ans: Key factors that are driving the market growth include an increase in diseases occurrence and growing drug amalgamation and increase research and development activities about available treatment.
1. Global Antiemetics Market: Research Methodology 2. Global Antiemetics Market: Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to Global Antiemetics Market 2.2. Summary 2.1.1. Key Findings 2.1.2. Recommendations for Investors 2.1.3. Recommendations for Market Leaders 2.1.4. Recommendations for New Market Entry 3. Global Antiemetics Market: Competitive Analysis 3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 12.79 Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • Latin America 3.12 COVID-19 Impact 4. Global Antiemetics Market Segmentation 4.1 Global Antiemetics Market, by Type (2020-2027) • 5-HT3 receptor antagonists • Dopamine antagonists • NK1 receptor antagonist • Antihistamines (H1 histamine receptor antagonists) • Cannabinoids • Benzodiazepines • Anticholinergics • Steroids • Others 4.2 Global Antiemetics Market, by Application (2020-2027) • Chemotherapy • Motion sickness • Gastroenteritis • General anesthetics • Opioid analgesics • Dizziness • Pregnancy • Food poisoning • Emotional stress • Others 5. North America Antiemetics Market (2020-2027) 5.1 North America Antiemetics Market, by Type (2020-2027) • 5-HT3 receptor antagonists • Dopamine antagonists • NK1 receptor antagonist • Antihistamines (H1 histamine receptor antagonists) • Cannabinoids • Benzodiazepines • Anticholinergics • Steroids • Others 5.2 North America Antiemetics Market, by Application (2020-2027) • Chemotherapy • Motion sickness • Gastroenteritis • General anesthetics • Opioid analgesics • Dizziness • Pregnancy • Food poisoning • Emotional stress • Others 5.3 North America Antiemetics Market, by Country (2020-2027) • United States • Canada • Mexico 6. Asia Pacific Antiemetics Market (2020-2027) 6.1. Asia Pacific Antiemetics Market, by Type (2020-2027) 6.2. Asia Pacific Antiemetics Market, by Application (2020-2027) 6.2. Asia Pacific Antiemetics Market, by Country (2020-2027) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 7. Middle East and Africa Antiemetics Market (2020-2027) 7.1. Middle East and Africa Antiemetics Market, by Type (2020-2027) 7.2. Middle East and Africa Antiemetics Market, by Application (2020-2027) 2.5. Middle East and Africa Antiemetics Market, by Country (2020-2027) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 8. Latin America Antiemetics Market (2020-2027) 8.1. Latin America Antiemetics Market, by Type (2020-2027) 8.2. Latin America Antiemetics Market, by Application (2020-2027) 8.3 Latin America Antiemetics Market, by Country (2020-2027) • Brazil • Argentina • Rest of Latin America 9. European Antiemetics Market (2020-2027) 9.1. European Antiemetics Market, by Type (2020-2027) 9.2. European Antiemetics Market, by Application (2020-2027) 9.3 European Antiemetics Market, by Country (2020-2027) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest of Europe 10. Company Profile: Key players 10.1. Veolia 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2. Teva Pharmaceutical 10.3. GlaxoSmithKline 10.4. Merck 10.5. Sanofi-Aventis 10.6. Bristol-Myers Squibb 10.7. Eli Lilly and Company 10.8. Pfizer 10.9. Astellas Pharma 10.10. Johnson & Johnson 10.11. Baxter International 10.12. Novartis AG 10.13. Abbott laboratories 10.14. Daiichi Sankyo 10.15. Eisai Co., Ltd. 10.16. Tesaro 10.17. Roche